217 related articles for article (PubMed ID: 37650104)
1. Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective.
Bordet S; Luaces JP; Herrera MI; Gonzalez LM; Kobiec T; Perez-Lloret S; Otero-Losada M; Capani F
Front Neurosci; 2023; 17():1215041. PubMed ID: 37650104
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.
Herrera MI; Udovin LD; Toro-Urrego N; Kusnier CF; Luaces JP; Otero-Losada M; Capani F
Front Neurosci; 2018; 12():339. PubMed ID: 29904335
[TBL] [Abstract][Full Text] [Related]
3. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia.
Duncombe J; Kitamura A; Hase Y; Ihara M; Kalaria RN; Horsburgh K
Clin Sci (Lond); 2017 Oct; 131(19):2451-2468. PubMed ID: 28963120
[TBL] [Abstract][Full Text] [Related]
4. Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia.
Gannon OJ; Naik JS; Riccio D; Mansour FM; Abi-Ghanem C; Salinero AE; Kelly RD; Brooks HL; Zuloaga KL
Biol Sex Differ; 2023 May; 14(1):34. PubMed ID: 37221553
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?
Du SQ; Wang XR; Xiao LY; Tu JF; Zhu W; He T; Liu CZ
Mol Neurobiol; 2017 Jul; 54(5):3670-3682. PubMed ID: 27206432
[TBL] [Abstract][Full Text] [Related]
6. A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis.
Yu W; Li Y; Hu J; Wu J; Huang Y
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012981
[TBL] [Abstract][Full Text] [Related]
7. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
Zhao Y; Gong CX
Cell Mol Neurobiol; 2015 Jan; 35(1):101-10. PubMed ID: 25352419
[TBL] [Abstract][Full Text] [Related]
8. Chronic cerebral hypoperfusion in male rats results in sustained HPA activation and hyperinsulinemia.
Lansdell TA; Dorrance AM
Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E24-E33. PubMed ID: 34747203
[TBL] [Abstract][Full Text] [Related]
9. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
10. Remote Ischemic Conditioning: A Potential Treatment for Chronic Cerebral Hypoperfusion.
Ma X; Ji C
Eur Neurol; 2022; 85(4):253-259. PubMed ID: 35104816
[TBL] [Abstract][Full Text] [Related]
11. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
Helman AM; Murphy MP
Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
[TBL] [Abstract][Full Text] [Related]
12. Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice.
Zhao Y; Gu JH; Dai CL; Liu Q; Iqbal K; Liu F; Gong CX
Front Aging Neurosci; 2014; 6():10. PubMed ID: 24575038
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.
Xu W; Bai Q; Dong Q; Guo M; Cui M
Front Cell Neurosci; 2022; 16():870674. PubMed ID: 35783093
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
Feng T; Yamashita T; Shang J; Shi X; Nakano Y; Morihara R; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2019; 71(1):327-339. PubMed ID: 31403949
[TBL] [Abstract][Full Text] [Related]
15. Chronic cerebral hypoperfusion induces memory deficits and facilitates Aβ generation in C57BL/6J mice.
Wang L; Du Y; Wang K; Xu G; Luo S; He G
Exp Neurol; 2016 Sep; 283(Pt A):353-64. PubMed ID: 27421879
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Sun H; Takemoto M; Yunoki T; Nakano Y; Morihara R; Abe K; Yamashita T
J Alzheimers Dis; 2022; 86(4):1973-1982. PubMed ID: 35253748
[TBL] [Abstract][Full Text] [Related]
17. FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway.
Zhang M; Hu Y; Zhang J; Zhang J
Front Aging Neurosci; 2020; 12():593364. PubMed ID: 33519419
[TBL] [Abstract][Full Text] [Related]
18. Physical Exercise-Induced Astrocytic Neuroprotection and Cognitive Improvement Through Primary Cilia and Mitogen-Activated Protein Kinases Pathway in Rats With Chronic Cerebral Hypoperfusion.
Cao W; Lin J; Xiang W; Liu J; Wang B; Liao W; Jiang T
Front Aging Neurosci; 2022; 14():866336. PubMed ID: 35721009
[TBL] [Abstract][Full Text] [Related]
19. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955
[TBL] [Abstract][Full Text] [Related]
20. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.
Liu H; Zhang J
Int J Neurosci; 2012 Sep; 122(9):494-9. PubMed ID: 22519891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
